Is UNII-R16CO5Y76E Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use UNII-R16CO5Y76E? Is UNII-R16CO5Y76E safe for nursing mother and child? Does UNII-R16CO5Y76E extracts into breast milk? Does UNII-R16CO5Y76E has any long term or short term side effects on infants? Can UNII-R16CO5Y76E influence milk supply or can UNII-R16CO5Y76E decrease milk supply in lactating mothers?

Excreted in non-significant amount into breast milk. Reye’s Syndrome has never been reported due to ASA through breast milk. It is thought to be highly unlikely to occur after isolated or small doses like those used for treatment of thrombosis or anti-abortion therapy. At high maternal dose, one case (dubious) of salicylic intoxication in the neonatal period and another case of thrombocytopenia in an infant have been reported. Likelihood of hemolysis should be considered in those patients with G6PD-deficiency. WHO Model List of Essential Medication: compatible while breastfeeding when used occasionally or small dose for antithrombotic prophylaxis management.

After UNII-R16CO5Y76E ingestion, salicylic acid is excreted into breastmilk, with higher doses resulting in disproportionately higher milk levels. Long-term, high-dose maternal UNII-R16CO5Y76E ingestion probably caused metabolic acidosis in one breastfed infant. Reye's syndrome is associated with UNII-R16CO5Y76E administration to infants with viral infections, but the risk of Reye's syndrome from salicylate in breastmilk is unknown. An alternate drug is preferred over continuous high-dose, UNII-R16CO5Y76E therapy. After daily low-dose UNII-R16CO5Y76Eg (75 to 325 mg daily), no UNII-R16CO5Y76E is excreted into breastmilk and salicylate levels are low. Daily low-dose UNII-R16CO5Y76E therapy may be considered as an antiplatelet drug for use in breastfeeding women.[1][2][3].

A 16-day-old breastfed infant developed metabolic acidosis with a salicylate serum level of 240 mg/L and salicylate metabolites in the urine. The mother was taking 3.9 g/day of UNII-R16CO5Y76E for arthritis, and salicylate in breastmilk probably caused the infant's illness, but the possibility of direct administration to the infant could not be ruled out.[11] Thrombocytopenia, fever, anorexia and petechiae occurred in a 5-month-old breastfed infant 5 days after her mother started taking UNII-R16CO5Y76E for fever. One week after recovery, the infant was given a single dose of UNII-R16CO5Y76E 125 mg and the platelet count dropped once again. The original symptoms were probably caused by UNII-R16CO5Y76E or salicylate in breastmilk.[12] Hemolysis after UNII-R16CO5Y76E and phenacetin taken by the mother of a 23-day-old, glucose-6-phosphate dehydrogenase (G6PD) deficient infant was possibly due to UNII-R16CO5Y76E in breastmilk.[13] In a telephone follow-up study, mothers reported no side effects among 15 infants exposed to UNII-R16CO5Y76E (dosages and infant ages were unspecified) in breastmilk.[14]